Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Added

RheumaPlay · SjS Pro 03

Where the Primary Endpoint Went

Twenty years of trials, most of them negative, a few of them finally not. Twelve questions on the numbers that matter — and on why a five-point placebo response is the real villain of this story.

Open demo · no registration required

8 questions from a pool of 12 · EN / RU / ES / PL

For clinicians. Virtual chips only; no money or prizes.

Related reading

Continue learning

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Clinical trialsInteractive learningMedical researchSjögren disease